IL17A and inflammatory bowel disease: In particular, in IBD, IL‐17A has a protective role in the gastrointestinal tract, while IL‐23 perturbs the balance between proinflammatory and anti‐inflammatory pathways, triggering colitis without systemic inflammation [18, 19].